Quantitative telemedicine ratings in Batten disease
Authors:
- 15 November 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 77 (20) , 1808-1811
Abstract
Objective: To determine if remote administration of the Unified Batten Disease Rating Scale (UBDRS) Physical Impairment subscale by telemedicine is reliable and feasible across a broad range of disease severity. Methods: For the majority (n = 10) of subjects, the examination was performed by a nonphysician who had been trained to perform the examination but not to score the subjects. A trained rater scored the subjects via live video; a second trained rater performed a separate examination in person and scored that examination. For 3 telemedicine evaluations, examinations were performed and scored by a trained rater while a second trained rater simultaneously scored the subjects via live video. Reliability was determined by intraclass correlation coefficient (ICC). Results: Subjects (n = 13) represented a wide range of disease severity. Remote administration of the UBDRS Physical Impairment subscale had high interrater reliability across all subjects (ICC = 0.94). When only the subjects (n = 10) who had been examined by the nonphysician and scored remotely were included in the analysis, the reliability was unchanged (ICC = 0.95). Conclusions: The UBDRS Physical Impairment subscale is reliable and feasible for remote administration. Telemedicine has the potential to be a useful tool in rare neurologic disease research and clinical assessment.Keywords
This publication has 8 references indexed in Scilit:
- Quantifying physical decline in juvenile neuronal ceroid lipofuscinosis (Batten disease)Neurology, 2011
- Quantitative telemedicine ratings in Batten diseaseNeurology, 2011
- Increasing access to specialty care: A pilot, randomized controlled trial of telemedicine for Parkinson's diseaseMovement Disorders, 2010
- Neuropsychological Symptoms of Juvenile-Onset Batten Disease: Experiences From 2 StudiesJournal of Child Neurology, 2007
- A clinical rating scale for Batten diseaseNeurology, 2005
- Homogeneous Polymerase Chain Reaction Nucleobase Quenching Assay to Detect the 1-kbp Deletion in CLN3 That Causes Batten DiseaseThe Journal of Molecular Diagnostics, 2004
- Dementia in the Neuronal Ceroidlipofuscinoses2001
- Neuronal ceroid lipofuscinoses in childhoodNeurological Sciences, 2000